FINWIRES · TerminalLIVE
FINWIRES

Trulieve Cannabis 将在佛罗里达州卢茨开设医用大麻药房

-- Trulieve Cannabis (TRUL.CN) 于周五宣布，将于4月11日在佛罗里达州卢茨市开设一家新的医用大麻药房。 该公司表示，新药房将提供“种类繁多的热门产品”，包括Trulieve旗下的自有品牌，例如Cultivar Collection、Modern Flower、Momenta、Roll One和Sweet Talk。 该公司在一份声明中指出，顾客还可以购买到“备受喜爱的合作伙伴品牌”，例如Alien Labs、Bellamy Brothers、Binske、Black Tuna、Blue River、Connected Cannabis、DeLisioso、Khalifa Kush、Love's Oven、Miami Mango、Seed Junky和Sunshine Cannabis，所有这些品牌在佛罗里达州的Trulieve药房均有独家销售。 Trulieve首席执行官Kim Rivers表示：“在温馨舒适的环境中提供高质量的产品是我们使命的核心。” “我们很高兴能为希尔斯伯勒县的患者提供便捷且充满关怀的医疗服务，助力他们的健康之旅。” 该公司股票在加拿大证券交易所的最新报8.87美元，与前一日持平。

Price: $8.91, Change: $+0.04, Percent Change: +0.45%

Related Articles

Research

Research Alert: CFRA Maintains Hold Rating On Shares Of United Rentals Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our 12-month target price to $1,100 from $950 following a strong first quarter, valuing shares at 20.5x our 2027 EPS outlook of $54.28 (in line with previous estimate; 2026 EPS also in line). We believe a higher multiple is justified given URI's firming market leadership within an expanding rental equipment industry. A robust Q1 beat enabled URI to raise its full-year revenue guidance to $16.9B-$17.4B and adjusted EBITDA to $7.625B-$7.875B, citing momentum heading into a busy season. With leverage well below historical levels, we believe accretive M&A deals could serve as a potential catalyst for additional guidance increases. Margin compression has been a sticky issue for URI, but Q1 indicated that pricing may have turned around and that headwinds are starting to ease as quarterly results begin to lap when tariff-related inflation began to pick-up. We remain cautious on margins, though are encouraged by signs of stabilization. New project activity is likely supporting pricing trends, in our view.

$URI
Equities

Petro Rabigh Emerges From Loss in Q1; Revenue Grows

Rabigh Refining and Petrochemical (SASE:2380), d/b/a Petro Rabigh, said Sunday it swung back to profit in the first quarter of 2026, while revenue increased year over year.Net profit attributable to shareholders of the issuer for the three months ended March 31 was 1.47 billion Saudi riyals, compared with the attributable loss of 691 million riyals earlier. EPS moved to 0.88 riyal from a loss per share of 0.41 riyal.The Tadawul-listed oil refining and petrochemical company's revenue was 14.85 billion riyals, compared with 11.21 billion riyals a year ago.

$SASE:2380
Research

Research Alert: CFRA Keeps Buy Opinion On Shares Of The Hartford Insurance Group, Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We trim our 12-month target price by $8 to $155, valuing HIG shares at 11.3x our 2026 operating EPS estimate of $13.75 (cut by $0.45) and at 10.6x our 2027 EPS estimate of $14.65 (cut by $0.30), vs. the shares' one-year average forward multiple of 10.3x and peer average of 13x. Q1 EPS of $3.09 vs. $2.20 a year ago missed our $3.60 estimate and $3.39 consensus view. Operating revenue growth of 6.2% was in line with our 6%-10% forecast, amid 5.3% earned premium growth, 13% higher net investment income, and 7.9% fee revenue growth. Q1 written premium growth of 4% and full-year 2025 growth of 7% bode well for 2026 revenue trends as premiums are earned. Underwriting results improved significantly, with Personal Lines combined ratio improving to 87.7% from 106.1% and underlying combined ratio to 85.0% from 89.7%. Business Insurance combined ratio was stable at 94.8%. Weighing the Q1 EPS miss with HIG's decent top-line growth and discounted valuation to peers, we view the shares as undervalued.

$HIG